指南与共识瓣膜病与结构性心脏病

18-60岁成人主动脉瓣置换术式选择的正式共识研究

Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
指南 / 共识 · Heart · 2023-05-15

该研究采用正式共识方法,由12名临床医生对7个领域68个临床场景下四种主动脉瓣置换术式(机械瓣、生物瓣、Ross手术、Ozaki手术)的适宜性进行两轮9分Likert评分。结果显示机械瓣和生物瓣共识度较高,Ross手术也有较高确定性,Ozaki手术共识度低,经导管主动脉瓣植入仅适用于少数场景。

要点

  • 机械瓣和生物瓣在多数场景下获共识适宜,Ross手术也有较高确定性。
  • Ozaki手术共识度低,仅3%场景共识适宜。
  • 经导管主动脉瓣植入仅7%场景共识适宜,如衰弱、手术风险禁忌。

核心结论

  • 除传统主动脉瓣置换选项外,Ross手术在18-60岁患者中有高度确定性适宜。
  • 未来临床指南应将Ross手术纳入主动脉瓣假体选择选项。

研究设计与样本

  • 正式共识研究,工作组在患者顾问组支持下制定7个领域(解剖、表现、心脏/非心脏合并症、同期治疗、生活方式、偏好)的临床场景列表。
  • 共识组由12名临床医生组成,在两次独立场合(1天会议前后)对每种手术方式在每个场景的适宜性进行9分Likert评分。

主要发现

  • 机械瓣置换共识适宜57%、不适宜19%,总共识度76%。
  • 生物瓣置换共识适宜68%、不适宜0%,总共识度68%。
  • Ross手术共识适宜39%、不适宜27%,总共识度66%。
  • Ozaki手术共识适宜3%、不适宜28%,总共识度31%。
  • 经导管主动脉瓣植入在68个场景中5个(7%)获共识适宜,包括衰弱、手术风险禁忌和预期寿命极有限。

关键数值与推荐

  • 共识判定基于9分Likert量表,适宜和不适宜的阈值原文未报告。
  • 经导管主动脉瓣植入共识适宜场景包括衰弱、手术风险禁忌和预期寿命极有限。

临床怎么用

  • 对于18-60岁主动脉瓣置换患者,除机械瓣和生物瓣外,应考虑Ross手术作为可选方案。
  • 经导管主动脉瓣植入仅推荐用于衰弱、手术风险禁忌或预期寿命极有限的特定患者。

局限性

  • 共识基于专家意见而非长期临床结局数据,证据级别有限。
  • 共识组仅12名临床医生,代表性可能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is uncertainty about surgical procedures for adult patients aged 18-60 years undergoing aortic valve replacement (AVR). Options include conventional AVR (mechanical, mAVR; tissue, tAVR), the pulmonary autograft (Ross) and aortic valve neocuspidisation (Ozaki). Transcatheter treatment may be an option for selected patients. We used formal consensus methodology to make recommendations about the suitability of each procedure. METHODS: A working group, supported by a patient advisory group, developed a list of clinical scenarios across seven domains (anatomy, presentation, cardiac/non-cardiac comorbidities, concurrent treatments, lifestyle, preferences). A consensus group of 12 clinicians rated the appropriateness of each surgical procedure for each scenario on a 9-point Likert scale on two separate occasions (before and after a 1-day meeting). RESULTS: There was a consensus that each procedure was appropriate (A) or inappropriate (I) for all clinical scenarios as follows: mAVR: total 76% (57% A, 19% I); tAVR: total 68% (68% A, 0% I); Ross: total 66% (39% A, 27% I); Ozaki: total 31% (3% A, 28% I). The remainder of percentages to 100% reflects the degree of uncertainty. There was a consensus that transcatheter aortic valve implantation is appropriate for 5 of 68 (7%) of all clinical scenarios (including frailty, prohibitive surgical risk and very limited life span). CONCLUSIONS: Evidence-based expert opinion emerging from a formal consensus process indicates that besides conventional AVR options, there is a high degree of certainty about the suitability of the Ross procedure in patients aged 18-60 years. Future clinical guidelines should include the option of the Ross procedure in aortic prosthetic valve selection.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Stoica S, Beard C, Takkenberg JJM, et al. Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years. Heart. 2023. PMID: 36849232. doi:10.1136/heartjnl-2022-321740

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。